Skip to main content

Allergy

13
Pipeline Programs
17
Companies
34
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
2
0
0
7
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

15 companies ranked by most advanced pipeline stage

Allergopharma
AllergopharmaGermany - Reinbek
4 programs
4
Allerslit fortePhase 31 trial
Recombinant grass pollenPhase 31 trial
recombinant birch pollen allergenPhase 31 trial
wasp venomPhase 31 trial
Active Trials
NCT00623701Completed126Est. Oct 2012
NCT00309036CompletedEst. May 2008
NCT00554983Completed255Est. May 2012
+1 more trials
Syneos Health
Syneos HealthNC - Morrisville
1 program
1
5-grass mix SLIT-dropsPhase 31 trial
Active Trials
NCT04881461Completed445Est. Sep 2023
DBV Technologies
DBV TechnologiesFrance - Châtillon
1 program
1
DBV712 250 mcgPhase 31 trial
Active Trials
NCT07003919Recruiting480Est. May 2028
Abbott
AbbottABBOTT PARK, IL
1 program
1
MitizaxPhase 31 trial
Active Trials
NCT02596321Completed112Est. Jun 2016
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
8 programs
1
2
NAETPhase 1/21 trial
NAET Testing ModalitiesPhase 1/21 trial
Intradermal cat allergen challengePhase 11 trial
Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory DisordersN/A1 trial
Nurse Led Allergy ClinicN/A1 trial
+3 more programs
Active Trials
NCT00557895Terminated288Est. Jun 2019
NCT03826953Completed250Est. Feb 2021
NCT07279467Not Yet Recruiting500Est. Oct 2027
+5 more trials
Sandoz
SandozAustria - Kundl
4 programs
3
Clemastine Fumarate Tablets, 2.68 mgPhase 11 trial
Promethazine HCl 50 mg TabletsPhase 11 trial
QGE031Phase 11 trial
Loratadine 10 mg Tablets Under Fasting ConditionsPHASE_11 trial
Active Trials
NCT00946608Completed30Est. Aug 2005
NCT00913549Completed36Est. Jan 1990
NCT00947063Completed36Est. Aug 2004
+1 more trials
Stallergenes Greer
Stallergenes GreerFrance - Antony
7 programs
OralairN/A1 trial
Subcutaneous immunotherapy - Recombinant birch pollenPHASE_21 trial
100 IR grass pollen allergen extract tabletPHASE_2_31 trial
300 IRPHASE_31 trial
300 IR grass pollen allergen extract tabletPHASE_31 trial
+2 more programs
Active Trials
NCT02295969Completed307Est. Jul 2017
NCT00410930Terminated160Est. Nov 2005
NCT00367640Completed628Est. Sep 2005
+4 more trials
Integrated Biosciences
Integrated BiosciencesCA - San Carlos
1 program
Blood draw, stool collection.N/A1 trial
Active Trials
NCT02931955Completed50Est. Jul 2019
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Understanding Allergies and Sensitizations in Healthy and Allergic IndividualsN/A
Genome & Company
Genome & CompanyKorea - Suwon
1 program
Understanding Allergies and Sensitizations in Healthy and Allergic IndividualsN/A
Sunshine Biopharma
Sunshine BiopharmaQC - Varennes
1 program
Understanding Allergies and Sensitizations in Healthy and Allergic IndividualsN/A
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
CetirizinePHASE_14 trials
Active Trials
NCT03772158Completed40Est. Feb 2019
NCT01322282Completed36Est. Mar 2011
NCT01068223Completed24Est. May 2010
+1 more trials
UCB Pharma
UCB PharmaBelgium - Brussels
1 program
LevocetirizinePHASE_11 trial
Active Trials
NCT00521170CompletedEst. Jan 2005
Regeneron
RegeneronTARRYTOWN, NY
1 program
REGN1908-1909PHASE_11 trial
Active Trials
NCT02127801Completed74Est. Dec 2015
Parexel
ParexelMA - Boston
1 program
Tree SLIT-tabletPHASE_31 trial
Active Trials
NCT04878354Completed952Est. Jul 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Johnson & JohnsonCetirizine
DBV TechnologiesDBV712 250 mcg
Syneos Health5-grass mix SLIT-drops
ParexelTree SLIT-tablet
AbbottMitizax
Stallergenes GreerSkin prick-test
AllergopharmaAllerslit forte
Stallergenes GreerStaloral
Allergopharmarecombinant birch pollen allergen
Stallergenes Greer300 IR
Stallergenes Greer300 IR grass pollen allergen extract tablet
AllergopharmaRecombinant grass pollen
Allergopharmawasp venom
Stallergenes Greer100 IR grass pollen allergen extract tablet
Stallergenes GreerSubcutaneous immunotherapy - Recombinant birch pollen

Showing 15 of 34 trials with date data

Clinical Trials (34)

Total enrollment: 10,111 patients across 34 trials

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

Start: Mar 2001Est. completion: Jul 2001683 patients
Phase 4Completed

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

Start: Jun 2025Est. completion: May 2028480 patients
Phase 3Recruiting
NCT04881461Syneos Health5-grass mix SLIT-drops

A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis

Start: May 2021Est. completion: Sep 2023445 patients
Phase 3Completed
NCT04878354ParexelTree SLIT-tablet

A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis

Start: Apr 2021Est. completion: Jul 2023952 patients
Phase 3Completed

A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma

Start: Oct 2015Est. completion: Jun 2016112 patients
Phase 3Completed

Sensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing

Start: Dec 2010Est. completion: Feb 2012324 patients
Phase 3Completed

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation

Start: Mar 2008Est. completion: Oct 2012126 patients
Phase 3Completed

A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites

Start: Oct 2007Est. completion: Jul 2009484 patients
Phase 3Completed
NCT00554983Allergopharmarecombinant birch pollen allergen

Efficacy and Safety From a Recombinant Folding Variant of Bet v 1

Start: Sep 2007Est. completion: May 2012255 patients
Phase 3Completed

Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets

Start: Dec 2006Est. completion: Sep 2011633 patients
Phase 3Completed
NCT00409409Stallergenes Greer300 IR grass pollen allergen extract tablet

Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis

Start: Dec 2006Est. completion: Sep 2007278 patients
Phase 3Completed
NCT00309036AllergopharmaRecombinant grass pollen

Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis

Start: Jan 2004Est. completion: May 2008
Phase 3Completed

Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

Start: Mar 2001Est. completion: Nov 2010
Phase 3Completed
NCT00367640Stallergenes Greer100 IR grass pollen allergen extract tablet

Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis

Start: Nov 2004Est. completion: Sep 2005628 patients
Phase 2/3Completed
NCT00410930Stallergenes GreerSubcutaneous immunotherapy - Recombinant birch pollen

Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Start: Nov 2002Est. completion: Nov 2005160 patients
Phase 2Terminated

Importance of Hand Washing After Each NAET® Treatment

Start: Dec 2005Est. completion: Dec 200560 patients
Phase 1/2Completed
NCT00292578Allergy TherapeuticsNAET Testing Modalities

NAET® Testing Devices in Detection of Hypersensitivity to Cane Sugar

Start: Jan 2005Est. completion: Jan 200675 patients
Phase 1/2Completed
NCT07447869Allergy TherapeuticsIntradermal cat allergen challenge

LYmph Node eXamination in Cat Allergen Immunotherapy

Start: Apr 2026Est. completion: Jan 202716 patients
Phase 1Recruiting

Cetirizine Chewable Bioequivalence and Food Effect Study

Start: Dec 2018Est. completion: Feb 201940 patients
Phase 1Completed

Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants

Start: Oct 2014Est. completion: Dec 201574 patients
Phase 1Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male Subjects

Start: Mar 2011Est. completion: Aug 2012209 patients
Phase 1Completed

To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy

Start: Feb 2011Est. completion: Mar 201136 patients
Phase 1Completed

A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male Volunteers

Start: Feb 2010Est. completion: May 201024 patients
Phase 1Completed
NCT00946608SandozLoratadine 10 mg Tablets Under Fasting Conditions

To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

Start: Jun 2005Est. completion: Aug 200530 patients
Phase 1Completed
NCT00521170UCB PharmaLevocetirizine

Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.

Start: Nov 2004Est. completion: Jan 2005
Phase 1Completed
NCT00947063SandozPromethazine HCl 50 mg Tablets

To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions

Start: Jul 2004Est. completion: Aug 200436 patients
Phase 1Completed
NCT00913549SandozClemastine Fumarate Tablets, 2.68 mg

To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets

Start: Dec 1989Est. completion: Jan 199036 patients
Phase 1Completed

Study of Oral Food Challenge Biomarkers (SAFER)

Start: Apr 2026Est. completion: Oct 2027500 patients
N/ANot Yet Recruiting
NCT03826953Allergy TherapeuticsNurse Led Allergy Clinic

Allergy UK Research and Development Nurse Project

Start: Jul 2017Est. completion: Feb 2021250 patients
N/ACompleted
NCT02931955Integrated BiosciencesBlood draw, stool collection.

Applying Systems Immunology to the Search for Personalized Biomarkers of Clinical Efficacy

Start: Aug 2016Est. completion: Jul 201950 patients
N/ACompleted

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Start: Dec 2014Est. completion: Jul 2017307 patients
N/ACompleted
NCT04828603Allergy TherapeuticsUnderstanding Allergies and Sensitizations in Healthy and Allergic Individuals

Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

Start: Oct 2007Est. completion: Dec 20282,500 patients
N/ARecruiting
NCT00405899Allergy TherapeuticsPilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections

Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections

Start: Oct 2006Est. completion: Dec 200920 patients
N/ACompleted
NCT00557895Allergy TherapeuticsEvaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders

Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders

Start: Aug 1996Est. completion: Jun 2019288 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

7 late-stage (Phase 3) programs, potential near-term approvals
3 actively recruiting trials targeting 10,111 patients
17 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.